Vimarsana
Biggest News Aggregation in the World

Page 13 - Nasdaq Bbio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Bbio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Bbio Today - Breaking & Trending Today

BridgeBio Pharma (NASDAQ:BBIO) Now Covered by Analysts at Cowen - Vimarsana News

BridgeBio Pharma (NASDAQ:BBIO) Now Covered by Analysts at Cowen

Cowen assumed coverage on shares of BridgeBio Pharma (NASDAQ:BBIO – Get Rating) in a research report report published on Monday morning, The Fly reports. The brokerage issued an outperform rating on the stock. BBIO has been the subject of a number of other research reports. JPMorgan Chase & Co. reduced their price objective on BridgeBio […]

BridgeBio Pharma (NASDAQ:BBIO) Coverage Initiated at Cowen - Vimarsana News

BridgeBio Pharma (NASDAQ:BBIO) Coverage Initiated at Cowen

Cowen initiated coverage on shares of BridgeBio Pharma (NASDAQ:BBIO – Get Rating) in a research report report published on Monday morning, Briefing.com reports. The firm issued an outperform rating on the stock. Several other research analysts also recently weighed in on the stock. SVB Leerink decreased their target price on shares of BridgeBio Pharma from […]

Profund Advisors LLC Cuts Holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO) - Vimarsana News

Profund Advisors LLC Cuts Holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO)

Profund Advisors LLC trimmed its holdings in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Rating) by 10.0% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 16,523 shares of the company’s stock after selling 1,839 shares during the period. Profund Advisors […]

BridgeBio Pharma (NASDAQ:BBIO) Shares Gap Up to $6.51 - Vimarsana News

BridgeBio Pharma (NASDAQ:BBIO) Shares Gap Up to $6.51

BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Rating) gapped up prior to trading on Wednesday . The stock had previously closed at $6.51, but opened at $6.78. BridgeBio Pharma shares last traded at $6.76, with a volume of 22,997 shares trading hands. BBIO has been the subject of several recent research reports. The Goldman Sachs Group […]

BridgeBio Pharma, Inc. (NASDAQ:BBIO) Given Consensus Rating of "Buy" by Analysts - Vimarsana News

BridgeBio Pharma, Inc. (NASDAQ:BBIO) Given Consensus Rating of "Buy" by Analysts

Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Rating) have been assigned a consensus recommendation of “Buy” from the seven brokerages that are currently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a hold rating and six have issued a buy rating on the company. The average twelve-month target price […]